All In MedTech

FDA Clearance Tracker · P830055-S107

LCS TOTAL KNEE SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Feb 22, 2011 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Feb 22, 2011

Approved

Time to decision

792 days

Received Dec 22, 2008. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P830055-S107
Device name
LCS TOTAL KNEE SYSTEM
Applicant
Depuy, Inc.
Applicant location
Warsaw, IN
Received
Dec 22, 2008
Decided
Feb 22, 2011
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P830055

Device type

Device class
Class III

Every decision under product code NJL

FDA's approval statement

As written in FDA's record.

APPROVAL TO MANUFACTURE THE SUBJECT COMPONENTS FROM GUR 1020 POLYETHYLENE WITH AN ANTIOXIDANT (AOX), TO CHANGE THE PACKAGING COMPONENTS AND MATERIALS, AND TO REQUEST APPROVAL OF A SHELF-LIFE TESTING PROTOCOL FOR THE SUBJECT P.F.C. SIGMA RP-F, LCS COMPLETE RP AND RPS TIBIAL INSERTS.

Source documents

Other decisions for Depuy, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.